Online inquiry

IVTScrip™ mRNA-Anti-oxLDL, BI-204(Cap 0, Pseudo-UTP, 120 nt-poly(A)) (CAT#: GTTS-WQ4097MR)

This product GTTS-WQ4097MR is a type of mRNA modified with Pseudo-UTP, which ecodes the monoclonal antibody that targets oxLDL gene. The antibody can be applied in Atherosclerosis research.

Specifications
Product type	mRNA
Modified bases	Pseudo-UTP
5' Cap	Cap 0
Species	Homo sapiens
RefSeq	NM_000041.4
Applications	Gene therapy research
Format	Powder
Quantity	100 µg
Purification	oligo-dT affinity purification

Target Gene
Gene ID	348
UniProt ID	P02649

Download
Download resources about mRNA therapeutics development to boost your research.

CUSTOMER REVIEWS and Q&As
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Anti-oxLDL, BI-204(Cap 0, Pseudo-UTP, 120 nt-poly(A)) (GTTS-WQ4097MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT	Product Name	Product Type	CDs
GTTS-WQ5954MR	IVTScrip™ mRNA-Anti-IGHE, CL-2C(Cap 1, 5-Methoxy-UTP, 30 nt-poly(A))	mRNA	CL-2C
GTTS-WQ12277MR	IVTScrip™ mRNA-Anti-CD274, MSB-0010718C(Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))	mRNA	MSB-0010718C
GTTS-WQ5375MR	IVTScrip™ mRNA-Anti-env, CD4(178) PE40(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	CD4(178) PE40
GTTS-WQ7067MR	IVTScrip™ mRNA-Anti-FAP, FAP-IL2v(Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))	mRNA	FAP-IL2v
GTTS-WQ1733MR	IVTScrip™ mRNA-Anti-CD40, ADC-1013(Cap 0, 2-Thio-UTP, 30 nt-poly(A))	mRNA	ADC-1013
GTTS-WQ10482MR	IVTScrip™ mRNA-Anti-CGRP, LY-2951742(Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A))	mRNA	LY-2951742
GTTS-WQ7846MR	IVTScrip™ mRNA-Anti-RTN4, GSK-1223249(Cap 1, Pseudo-UTP, 120 nt-poly(A))	mRNA	GSK-1223249
GTTS-WQ14259MR	IVTScrip™ mRNA-Anti-ERBB3, RG-7116(Cap 0, Pseudo-UTP, 120 nt-poly(A))	mRNA	RG-7116

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST